pipette
ESEspañol

The plateau in liver disease mortality in Germany: contrasting trends by age, region and ICD-10 code, 2000-2024

M. Kumpf, E. Stambollxhiu, E. Wende, N. Lenhart, M. Graf, S. Ziegelmayer, M. Makowski, K. Bressem, L. Adams

PreprintReal-world use

In the authors' words

Background: Cirrhosis is often diagnosed only at decompensation, making identification of high-risk groups important for prevention and early detection. Chronic liver disease mortality has fallen in southern Europe and France since 2010, but not in Germany. Whether the German plateau reflects birth-cohort alcohol exposure, metabolic liver disease or certification practice is unknown. Methods: Deaths by ICD-10 code, sex and age group were extracted from the WHO Mortality Database for 16 European countries (2000-2022), with Eurostat rates (2011-2023), German state-level mortality (1998-2024) and hospital diagnoses (2000-2023). Registry and Global Burden of Disease Study (GBD) 2023 estimates were summarised for ages 45-64, 65-74 and 75 years and over, with registry rates standardised to the European Standard Population 2013. Findings: Germany's age-standardised chronic liver disease mortality was 16.6 per 100 000 in 2011 and 16.0 in 2023, against declines of 21-37% in France, Italy and Spain. Between 2010 and 2022, alcoholic liver disease mortality at ages 45-64 fell by 17% in men and 25% in women, whereas fibrosis and cirrhosis (K74) mortality at ages 65-74 rose by 27% and 28%, with larger K70-K77 mortality increases in eastern than western Germany. Hospitalisation rates showed similar age-specific patterns, while in-hospital case fatality declined. Fewer than 0.5% of liver deaths were certified as fatty liver. GBD 2023 showed a similar age-specific increase but attributed rising mortality to all five modelled aetiologies. Interpretation: The German plateau reflects continued decline below age 65 and rising mortality at ages 65-74, compatible with cohorts born 1945-59 reaching this age band, particularly in eastern Germany. Consumption records and surveys indicate differing regional patterns of alcohol exposure. Much of the cirrhosis in these cohorts is certified without aetiology, and GBD's aetiological estimates cannot be verified in registration data. Funding: None.

Main resultLimitation the authors admit

Appeared: Thursday, November 19. medRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.11.16.26368157